Asian Pacific Journal of Cancer Prevention

  • 제15권1호
  • /
  • Pages.61-67
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Prognostic Factors in Adult Patients with Solid Cancers and Bone Marrow Metastases

  • Hung, Yu-Shin (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University) ;
  • Chou, Wen-Chi (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University) ;
  • Chen, Tai-Di (Department of Pathology, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University) ;
  • Chen, Tse-Ching (Department of Pathology, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University) ;
  • Wang, Po-Nan (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University) ;
  • Chang, Hung (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University) ;
  • Hsu, Hung-Chih (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University) ;
  • Shen, Wen-Chi (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University) ;
  • Cheng, Wei-Hong (Division of Hematology and Oncology, Departement of Internal Medicine, Taipei Medical University-Shung Ho hospital, Ministry of Health and Welfare) ;
  • Chen, Jen-Shi (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University)
  • 발행 : 2014.01.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Solid cancers with bone marrow metastases are rare but lethal. This study aimed to identify clinical factors predictive of survival in adult patients with solid cancers and bone marrow metastases. Methods: A total of 83 patients were enrolled consecutively between January 1, 2000 and December 31, 2012. Bone marrow metastases were confirmed by biopsies. Patient clinical features and laboratory data were analyzed for associations. Results: The median age of the patients was 54 years (range, 23-88 years), and 58% were male. The 3 most common primary tumor locations were the stomach (32 patients, 39%), prostate (16 patients, 19%), and lungs (12 patients, 15%). The median overall survival was 49 days (range, 3-1423 days). Patients with Eastern Cooperative Oncology Group performance status 1, cancers of prostate origin, platelet counts over 50,000/ml, and undergoing antitumor therapies had a significantly better prognosis in the multivariate analysis. The median survival times were 173 and 33 days for patients with 2-3 more favorable parameters (n=24) and those with 0-1 (n=69), respectively (hazard ratio 0.30; 95% CI 0.17-0.52, p<0.001). Conclusions: Solid cancers with bone marrow metastases are dismal and incurable diseases. Understanding prognostic factors to these diseases helps medical personnel to provide appropriate treatments and better inform patients about outcomes. Antitumor therapies may improve outcomes in selected patient cohorts.

키워드

참고문헌

  1. Al-Sarraf M, LeBlanc M, Giri PG, et al (1988). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol, 16, 1310-7.
  2. Burkhardt R, Frisch B, Bartl R, et al (1981). Detection of haematologic and nonhaematologic cancer by bone biopsy. Cancer Detect Prev, 4, 619-27.
  3. Ceci G, Franciosi V, Passalacqua R, et al (1988). The value of bone marrow biopsy in breast cancer at the time of first relapse: a prospective study. Cancer, 61, 1041-5. https://doi.org/10.1002/1097-0142(19880301)61:5<1041::AID-CNCR2820610531>3.0.CO;2-F
  4. Diel IJ, Kaufmann M, Goemer R, et al (1992). Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastases. J Clin Oncol, 10, 1534-9.
  5. Dunn P, Shih LY, Liaw SJ, Sun CF (1993). Bone marrow necrosis in 38 adult cancer patients. J Formos Med Assoc, 92, 1107-10.
  6. Eisenhauer EA, Therasse P, Bogaerts J, et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47. https://doi.org/10.1016/j.ejca.2008.10.026
  7. Forrest DL, Mack BJ, Nevill TJ, et al (2000). Bone marrow necrosis in adult acute leukemia and non-Hodgkin's lymphoma. Leuk Lymphoma, 38, 627-32. https://doi.org/10.3109/10428190009059283
  8. Hansen HH, Muggia FM, Selawry OS (1971). Bone marrow examination in 100 consecutive patients with bronchogenic carcinoma. Lancet, 2, 443-5.
  9. Kim HS, Yi SY, Jun HJ, et al (2007). Clinical outcome of gastric cancer patients with bone marrow metastases. Oncology, 73, 192-7. https://doi.org/10.1159/000127386
  10. Kwon JY, Yun J, Kim HJ, et al (2011). Clinical outcome of gastric cancer patients with bone marrow metastases. Cancer Res Treat, 43, 244-9. https://doi.org/10.4143/crt.2011.43.4.244
  11. McFarland W, Dameshek W (1958). Biopsy of bone marrow with the Vim-Silverman needle. JAMA, 166, 1464-6. https://doi.org/10.1001/jama.1958.62990120004011a
  12. Mehdi SR, Bhatt ML (2011). Metastasis of Solid Tumors in Bone Marrow: A Study from Northern India. Indian J Hematol Blood Transfus, 27, 93-5. https://doi.org/10.1007/s12288-011-0069-z
  13. Ozkalemkas F, Ali R, Ozkocaman V, et al (2005). The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases. BMC Cancer, 5, 144. https://doi.org/10.1186/1471-2407-5-144
  14. Papac RJ (1994). Bone marrow metastases: a review. Cancer, 74, 2403-13. https://doi.org/10.1002/1097-0142(19941101)74:9<2403::AID-CNCR2820740904>3.0.CO;2-F
  15. Paydas S, Ergin M, Baslamisli F, et al (2002). Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature. Am J Hematol, 70, 300-5. https://doi.org/10.1002/ajh.10114
  16. Ringenberg QS, Doll DC, Yarbro JW, Perry MC (1986). Tumors of unknown origin in the bone marrow. Arch Intern Med, 146, 2027-8. https://doi.org/10.1001/archinte.1986.00360220193031
  17. Sar R, Aydogdu I, Ozen S, Sevinc A, Buyukberber S (2001). Metastatic bone marrow tumours: a report of six cases and review of the literature. Haematologia (Budap), 31, 215-23. https://doi.org/10.1163/15685590152763755
  18. Shah NT, Tuttle SE, Strobe1 SL, Gandhi L (1985). Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material. J Surg Oncol, 29, 265-8. https://doi.org/10.1002/jso.2930290416
  19. Taiwan Health Registry Annual Report (2009). Bureau of Health Promotion, Department of Health, Executive Yuan, Republic of China. Available from: http://www2.cmu.edu.tw/-biostat/ online/DOH1000602.pdf (Last accessed May 20 2013)
  20. Trillet-Lenoir VN, Arpin D, Brune J (1994). Bone marrow metastases detection in small cell lung cancer. A review. Anticancer Res, 14, 2795-7.
  21. Tritz DB, Doll DC, Ringenberg QS, et al (1989). Bone marrow involvement in small cell lung cancer. Cancer, 63, 763-6. https://doi.org/10.1002/1097-0142(19890215)63:4<763::AID-CNCR2820630426>3.0.CO;2-F
  22. Wang JM, Shin LY, Lai GM, NG KT (1987). Bone marrow metastases from solid Tumors: clinical analysis of 96 cases. Chang Gung Med J, 10, 283-93.
  23. Wong KF, Chan JK, Ma SK (1993). Solid tumour with initial presentation in the bone marrow-a clinicopathologic study of 25 adult cases. Hematol Oncol, 11, 35-42. https://doi.org/10.1002/hon.2900110105
  24. Xiao L, Luxi S, Ying T, et al (2009). Diagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samples. J Cancer Res Clin Oncol, 135, 687-93. https://doi.org/10.1007/s00432-008-0503-2

피인용 문헌

  1. Retrograde Analysis of Clinical Characteristics of Bone Metastasis in 1,031 Cases of Preliminarily Diagnosed Nasopharyngeal Carcinoma vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3785
  2. Nasopharyngeal Carcinoma with Bone Marrow Metastasis: Positive Response to Weekly Paclitaxel Chemotherapy vol.54, pp.11, 2015, https://doi.org/10.2169/internalmedicine.54.3917
  3. Base of tongue squamous cell carcinoma with infiltrative bone marrow carcinomatosis after definitive chemoradiation: A case report vol.38, pp.7, 2016, https://doi.org/10.1002/hed.24155
  4. Predictive Value of Clinical and Laboratory Parameters for Overt Bone Marrow Metastasis in Patients with Solid Malignancy vol.08, pp.08, 2017, https://doi.org/10.4236/jct.2017.88067
  5. Analysis of therapy-relevant receptors in bone marrow carcinosis vol.38, pp.4, 2017, https://doi.org/10.1007/s00292-017-0300-2
  6. Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow Metastases vol.94, pp.23, 2015, https://doi.org/10.1097/MD.0000000000000966